In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Young teens might think smoking makes them look cool, but it’s likely to take their breath away in adulthood, a new st ...
A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...
On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...
Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...